Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation - Gramley, F; Lorenzen, J; Plisiene, J (J Cardiovasc Electrophysiol, 2007)
et al.